Nguyen Thuy Mi, Melichova Daniela, Aabel Eivind W, Lie Øyvind H, Klæboe Lars Gunnar, Grenne Bjørnar, Sjøli Benthe, Brunvand Harald, Haugaa Kristina, Edvardsen Thor
Department of Cardiology, Hospital of Southern of Norway, 4604 Kristiansand, Norway.
ProCardio, Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, 0424 Oslo, Norway.
J Clin Med. 2023 Oct 18;12(20):6598. doi: 10.3390/jcm12206598.
Our objective was to compare long-term outcomes in patients with non-ST-elevation myocardial infarction (NSTEMI) and ST-elevation myocardial infarction (STEMI) between two time periods in Southern Norway. There are limited contemporary data comparing long-term follow-up after revascularization in the last decades. This prospective follow-up study consecutively included both NSTEMI and STEMI patients during two time periods, 2014-2015 and 2004-2009. Patients were followed up for a period of 5 years. The primary outcome was all-cause mortality after 1 and 5 years. A total of 539 patients with acute myocardial infarction (AMI), 316 with NSTEMI (234 included in 2014 and 82 included in 2007) and 223 with STEMI (160 included in 2014 and 63 included in 2004). Mortality after NSTEMI was high and remained unchanged during the two time periods (mortality rate at 1 year: 3.5% versus 4.9%, = 0.50; and 5 years: 11.4% versus 14.6%, = 0.40). Among STEMI patients, all-cause mortality at 1 year was reduced in 2014 compared to 2004 (1.3% versus 11.1%, < 0.001; and 5 years: 7.0% versus 22.2%, = 0.004, respectively). Time to coronary angiography in NSTEMI patients remained unchanged between 2014 and 2007 (28.2 h [IQR 18.1-46.3] versus 30.3 h [IQR 18.0-48.3], = 0.20), while time to coronary angiography in STEMI patients was improved in 2014 compared with 2004 (2.8 h [IQR 2.0-4.8] versus 21.7 h [IQR 5.4-27.1], < 0.001), respectively. During one decade of AMI treatment, mortality in patients with NSTEMI remained unchanged while mortality in STEMI patients decreased, both at 1 and 5 years.
我们的目标是比较挪威南部两个时间段内非ST段抬高型心肌梗死(NSTEMI)和ST段抬高型心肌梗死(STEMI)患者的长期预后。在过去几十年中,关于血运重建术后长期随访的当代数据有限。这项前瞻性随访研究在2014 - 2015年和2004 - 2009年这两个时间段连续纳入了NSTEMI和STEMI患者。对患者进行了为期5年的随访。主要结局是1年和5年后的全因死亡率。共有539例急性心肌梗死(AMI)患者,其中316例为NSTEMI(2014年纳入234例,2007年纳入82例),223例为STEMI(2014年纳入160例,2004年纳入63例)。NSTEMI患者的死亡率较高,且在两个时间段内保持不变(1年死亡率:3.5%对4.9%,P = 0.50;5年死亡率:11.4%对14.6%,P = 0.40)。在STEMI患者中,2014年与2004年相比,1年全因死亡率有所降低(1.3%对1月1.1%,P < 0.001;5年死亡率:7.0%对22.2%,P = 0.004)。2014年至2007年期间,NSTEMI患者进行冠状动脉造影的时间保持不变(28.2小时[四分位间距18.1 - 46.3]对30.3小时[四分位间距18.0 - 48.3],P = 0.20),而2014年与2004年相比,STEMI患者进行冠状动脉造影的时间有所改善(2.8小时[四分位间距2.0 - 4.8]对21.7小时[四分位间距5.4 - 27.1],P < 0.001)。在AMI治疗的十年间,NSTEMI患者的死亡率保持不变,而STEMI患者在1年和5年时的死亡率均有所下降。